These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9304490

  • 21. Diabetes is a vascular disease.
    Hsueh WA, Law RE.
    J Investig Med; 1998 Oct; 46(8):387-90. PubMed ID: 9805424
    [No Abstract] [Full Text] [Related]

  • 22. Coagulation and fibrinolysis in diabetes.
    Banga JD.
    Semin Vasc Med; 2002 Feb; 2(1):75-86. PubMed ID: 16222598
    [Abstract] [Full Text] [Related]

  • 23. [Diabetes, coagulation and vascular events].
    Nenci GG, Paliani U.
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [Abstract] [Full Text] [Related]

  • 24. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I, Hans M.
    Bull Acad Natl Med; 2003 Feb; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dyslipidaemia and coagulation defects of insulin resistance.
    Frohlich J, Steiner G.
    Int J Clin Pract Suppl; 2000 Oct; (113):14-22. PubMed ID: 11965826
    [Abstract] [Full Text] [Related]

  • 27. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.
    Yamamoto K, Takeshita K, Kojima T, Takamatsu J, Saito H.
    Cardiovasc Res; 2005 May 01; 66(2):276-85. PubMed ID: 15820196
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fibrinolytic factors and atherothrombotic events: epidemiological evidence.
    Folsom AR.
    Ann Med; 2000 Dec 01; 32 Suppl 1():85-91. PubMed ID: 11209988
    [Abstract] [Full Text] [Related]

  • 30. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A, Gocke CD, Hess J, Heyman M, Paltiel M, Gaspari A.
    Arch Dermatol; 2006 Nov 01; 142(11):1466-9. PubMed ID: 17116837
    [Abstract] [Full Text] [Related]

  • 31. Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis.
    Eriksson MA, Rask E, Johnson O, Carlström K, Ahrén B, Eliasson M, Boman K, Söderberg S.
    Blood Coagul Fibrinolysis; 2008 Oct 01; 19(7):625-32. PubMed ID: 18832901
    [Abstract] [Full Text] [Related]

  • 32. [Tissue plasminogen activator and diabetes mellitus].
    Galajda P, Martinka E, Kubisz P, Mokán M.
    Vnitr Lek; 1998 Nov 01; 44(11):661-4. PubMed ID: 10422507
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis.
    Sobel BE, Taatjes DJ, Schneider DJ.
    Arterioscler Thromb Vasc Biol; 2003 Nov 01; 23(11):1979-89. PubMed ID: 12920048
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.
    Carmassi F, De Negri F, Fioriti R, De Giorgi A, Giannarelli C, Fruzzetti F, Pedrinelli R, Dell'Omo G, Bersi C.
    Thromb Res; 2005 Nov 01; 116(3):207-14. PubMed ID: 15935829
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.